The table below shows Jazz Pharmaceuticals plc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$1.07B
$1.13B
$1.05B
$897.80M
$1.05B
$1.02B
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
JAZZ annual revenue (10-K history)
Jazz Pharmaceuticals plc reported annual revenue of $4.27B for fiscal year 2025. That is up 4.9% from $4.07B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.49B (FY 2016) to $4.27B. Figures come from the company's audited annual reports as filed with the SEC.
